Calcium-permeable presynaptic AMPA receptors in cerebellar molecular layer interneurones.
Axons of cerebellar molecular layer interneurones (MLIs) bear ionotropic glutamate receptors. Here, we show that these receptors elicit cytosolic [Ca2+] transients in axonal varicosities following glutamate spillover induced by stimulation of parallel fibres (PFs). A spatial profile analysis indicates that these transients occur at the same locations when induced by PF stimulation or trains of action potentials. They are not affected by the NMDAR antagonist AP-V, but are abolished by the AMPAR inhibitor GYKI-53655. Mimicking glutamate spillover by a puff of AMPA triggers axonal [Ca2+]i transients even in the presence of TTX. Addition of specific voltage-dependent Ca2+ channel (VDCC) blockers such as omega-AGAIVA and omega-conotoxin GVIA or broad range inhibitors such as Cd2+ did not significantly inhibit the signal indicating the involvement of Ca2+-permeable AMPARs. This hypothesis is further supported by the finding that the subunit specific AMPAR antagonist IEM-1460 blocks 75% of the signal. Bath application of AMPA increases the frequency and mean peak amplitude of GABAergic mIPSCs, an effect that is blocked by philanthotoxin-433 (PhTx) and reinforced by facilitating concentrations of ryanodine. By contrast, a high concentration of ryanodine or dantrolene reduced the effects of AMPA on mIPSCs. Single-cell RT-PCR experiments show that all GluR1-4 subunits are potentially expressed in MLI. Taken together, the results suggest that Ca2+-permeable AMPARs are colocalized with VDCCs in axonal varicosities and can be activated by glutamate spillover through PF stimulation. The AMPAR-mediated Ca2+ signal is amplified by Ca2+-induced Ca2+ release from intracellular stores, leading to GABA release by MLIs.
Rossi
Bénédicte
B
Laboratoire de Physiologie Cérébrale, CNRS-UMR 8118, Université Paris Descartes, 45 rue des Saints Pères, 75006 Paris, France.
Maton
Gilliane
G
Collin
Thibault
T
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001369:Axons / Q000502:physiology; D002118:Calcium / Q000378:metabolism*; D002531:Cerebellum / Q000166:cytology*; D005786:Gene Expression Regulation / Q000502:physiology; D007395:Interneurons / Q000187:drug effects / Q000502:physiology*; D018408:Patch-Clamp Techniques; D021122:Protein Subunits; D011689:Purkinje Cells; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000378:metabolism*; D017470:Receptors, Glutamate / Q000235:genetics / Q000378:metabolism; D012433:Ryanodine / Q000494:pharmacology
D021122:Protein Subunits; D018091:Receptors, AMPA; D017470:Receptors, Glutamate; D012433:Ryanodine; D002118:Calcium
J Comp Neurol. 1992 Apr 15;318(3):329-54
1374769
Neuron. 2003 Jun 19;38(6):929-39
12818178
Nat Rev Neurosci. 2004 Apr;5(4):304-16
15034555
Eur J Neurosci. 2004 May;19(9):2464-74
15128400
Neuron. 2007 Jun 21;54(6):859-71
17582328
Nat Neurosci. 1998 Nov;1(7):572-8
10196564
J Neurosci. 1998 Oct 15;18(20):8214-27
9763467
J Physiol. 1997 Dec 15;505 ( Pt 3):655-63
9457643
J Neurosci. 1993 Sep;13(9):3904-15
8103555
J Neurosci. 1994 Sep;14(9):5525-47
8083752
Neuron. 2005 Mar 24;45(6):903-15
15797551
J Neurophysiol. 2004 Sep;92(3):1558-65
15152021
J Neurosci. 2006 Nov 8;26(45):11786-97
17093099
J Neurophysiol. 2007 Jul;98(1):550-6
17537903
Nature. 2006 Oct 12;443(7112):705-8
17036006
J Physiol. 1993 Aug;468:177-200
7504726
J Neurosci. 2004 Aug 4;24(31):6946-57
15295030
Neuron. 1993 Jun;10(6):1131-40
7686380
J Neurosci. 1994 May;14(5 Pt 1):2830-43
8182442
J Physiol. 1998 Jun 15;509 ( Pt 3):817-31
9596802
Curr Opin Neurobiol. 2006 Jun;16(3):288-97
16713244
Br J Pharmacol. 2000 Jan;129(2):265-74
10694232
Neuron. 1994 Jun;12(6):1331-43
7912092
Pharmacol Rev. 1999 Mar;51(1):7-61
10049997
Neuroscience. 1993 Feb;52(3):515-39
8450957
J Physiol. 2000 Aug 15;527 Pt 1:33-48
10944168
Nat Neurosci. 2000 Dec;3(12):1256-65
11100146
Biol Cell. 2004 May;96(4):257-60
15145529
J Neurosci. 2000 Jun 15;20(12):4423-34
10844011
Physiol Rev. 1995 Oct;75(4):759-87
7480162
Neuroscientist. 2006 Aug;12(4):317-26
16840708
J Neurosci. 1996 Nov 1;16(21):6634-47
8824304
Science. 1990 Aug 3;249(4968):556-60
2166337
J Neurosci. 2005 Jan 5;25(1):96-107
15634771
Neuron. 1993 Oct;11(4):771-87
8104433
J Neurosci. 2002 May 15;22(10):3881-9
12019307
Neuron. 1994 Mar;12(3):529-40
7512349
Neuropharmacology. 2007 Jun;52(8):1631-40
17493642
Nat Neurosci. 2000 Jun;3(6):551-8
10816310
J Physiol. 2007 Sep 1;583(Pt 2):537-53
17584840
Neuron. 1997 Jul;19(1):139-50
9247270
Nature. 2000 May 25;405(6785):454-8
10839540
Neuroscience. 1997 Nov;81(2):427-36
9300432
J Neurosci. 1997 Dec 15;17(24):9393-406
9390995
J Neurophysiol. 2005 Nov;94(5):3357-67
16000529
J Neurosci. 2005 May 18;25(20):4930-40
15901774
Neuron. 1993 Dec;11(6):1069-82
7506043
Nat Neurosci. 2004 May;7(5):525-33
15097992
Nature. 2004 Apr 22;428(6985):856-60
15103377
Nat Neurosci. 2005 Jun;8(6):768-75
15895086
Neuron. 2007 Mar 15;53(6):843-55
17359919
J Neurosci. 1999 Jan 15;19(2):511-9
9880571
J Physiol. 1999 Oct 1;520 Pt 1:65-78
10517801
Neuron. 1993 Jun;10(6):1185-96
7686382
J Neurosci. 2006 Feb 22;26(8):2278-89
16495455
J Neurosci. 2006 Sep 6;26(36):9332-9
16957089
J Comp Neurol. 1997 Sep 1;385(3):456-76
9300771
Nat Rev Neurosci. 2004 Feb;5(2):135-45
14735116
J Neurosci. 2005 Feb 23;25(8):2024-31
15728842
Eur J Pharmacol. 1990 Mar 13;178(1):11-9
2332027